ASX Announcements 2010 ASX Announcements 2009 ASX Announcements 2008 ASX Announcements 2007 ASX Announcements 2006 ASX Announcements 2005 ASX Announcements 2004 ASX Announcements 2003 ASX Announcements 2002 Should you wish to view the report in your browser, you will need to have the Acrobat Reader installed. Please click on the icon (right) and follow the instructions. ASX Announcements 2003 Change of Director's Interest Notice 24/12/2003   Appendix 3B - End of Restriction Period 22/12/2003   Updated Corporate Presentation 16/12/2003   Investor Update 09/12/2003   Securities to be Released from Escrow 05/12/2003   Appendix 3B Issue of shares approved at 2003 AGM 07/11/2003   Results of Annual General Meeting 31/10/2003   AGM Presentation 31/10/2003   Appendix 4C - First Quarter Report 20/10/2003   Cash Reserves of $15.4 million - no borrowings 20/10/2003   Change of Director's Interest 14/10/2003   Share Purchase Plan Raises $5.4 Million 08/10/2003   2003 Annual Report and Notice of Annual General Meeting 26/09/2003   Appendix 3B - Exercise of Options 22/09/2003   Share Purchase Plan 02/09/2003   Commencement of Phase I Study for MS Drug 27/08/2003   2003 Financial Accounts - App 4E 22/08/2003   Information Notification & Application for Quotation 22/08/2003   Share Placement 20/08/2003   Updated Corporate Presentation 13/08/2003   Appendix 4C - Quarterly Report 31/07/2003   ATL to Initiate "Proof Of Concept" Study for Psoriasis Project 24/07/2003   Presentation - Boston Bio-Relationships Conference 17/06/2003   Antisense Psoriasis Therapy Achieves Important Milestone 05/06/2003   $1.1 Million R&D Start Grant Approved for Psoriasis Project 19/05/2003   Appendix 4C - Quarterly Report 28/04/2003   Company Presentation 28/03/2003   Investor Update 18/02/2003   Half-Yearly Report (Appendix 4B)& Operations Report 31 December 2002 07/02/2003   Approval for Trials to Commence on new MS Treatment 04/02/2003   Appendix 4c Quarterly Report 31/01/2003